Aurobindo Pharma's Q4 net up 2% to ₹921 crore

Aurobindo Pharma's profit grew 2% to ₹921 crore in Q4 FY26. The company's total revenue also went up by 5.6%. Vice-Chairman K. Nithyananda Reddy said, "we are encouraged by our performance." He added that good volumes and efficiency helped their results, and they are confident about future growth.